Lupin Limited (Lupin), a global pharmaceutical powerhouse, has been awarded the Establishment Inspection Report (EIR) by the United States Food and Drug Administration (U.S. FDA). The EIR pertains to Lupin’s manufacturing facility located in Dabhasa, Gujarat, following an inspection that took place from April 8 to April 12, 2024. This rigorous inspection concluded without any […]
Global pharmaceutical major, Lupin Limited (Lupin), has announced receiving the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (U.S. FDA) for its Mandideep Unit-2 manufacturing facility. This report, indicating a significant milestone, was issued following the facility’s recent inspection, held from August 7 to August 11, 2023. Remarkably, the inspection concluded […]
